| Literature DB >> 25599058 |
S Sina1, B Zeinali2, M Karimipoorfard2, F Lotfalizadeh2, M Sadeghi2, E Zamani2, R Faghihi3.
Abstract
BACKGROUND: Dose assessment using proper dosimeters is especially important in radiation protection optimization and imaging justification in diagnostic radiology.Entities:
Keywords: Entrance Skin Dose; Rando phantom; TLD-100
Year: 2014 PMID: 25599058 PMCID: PMC4289519
Source DB: PubMed Journal: J Biomed Phys Eng ISSN: 2251-7200
Annealing procedure used for TLD-100, and GR-200 dosimeters
|
|
|
|---|---|
| TLD-100 |
1hour at 400°c |
| GR-200 | 10 minutes at 240°c |
Time temperature profile used for reading out TLD-100, and GR-200 chips
|
|
| |
|---|---|---|
|
| Preheat | |
| Temp (◦C) | 50 | |
| Time (sec) | 0 | |
| Acquisition | ||
| Max Temp(◦C) | 300 | |
| Time (sec) | 13.33 | |
| Rate (◦C/sec) | 25 | |
| Anneal | ||
| Temp (◦C) | 0 | |
| Time (sec) | 0 | |
|
| Preheat | |
| Temp (◦C) | 135 | |
| Time (sec) | 5 | |
| Acquisition | ||
| Max Temp (◦C) | 240 | |
| Time (sec) | 13 | |
| Rate (◦C/sec) | 20 | |
| Anneal | ||
| Temp (◦C) | 0 | |
| Time (sec) | 0 | |
Comparison of the dose measured by LiF
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 1 | 2 | 70 | 40 | 15.00 | 15.89 | -5.93% |
| 70 | 64 | |||||
| 2 | 3 | 80 | 50 | 17.87 | 17.22 | 3.64% |
| 80 | 63 | |||||
| 80 | 63 | |||||
| 3 | 5 | 66 | 40 | 25.99 | 23.41 | 9.93% |
| 86 | 50 | |||||
| 86 | 50 | |||||
| 72 | 64 | |||||
| 72 | 64 | |||||
| 4 | 2 | 70 | 56 | 11.80 | 11.29 | 4.32% |
| 85 | 71 | |||||
| 5 | 2 | 63 | 40 | 8.78 | 8.49 | 3.30% |
| 66 | 64 | |||||
| 6 | 2 | 66 | 28 | 8.80 | 8.72 | 0.91% |
| 69 | 71 | |||||
| 7 | 2 | 67 | 50 | 5.27 | 4.81 | 8.73% |
| 75 | 64 | |||||
| 8 | 2 | 64 | 20 | 5.01 | 5.49 | -9.58% |
| 68 | 32 | |||||
| 9 | 2 | 63 | 40 | 9.62 | 9.48 | 1.46% |
| 66 | 64 | |||||
| 10 | 2 | 73 | 50 | 11.60 | 11.05 | 4.74% |
| 71 | 80 | |||||
| 11 | 4 | 86 | 50 | 14.55 | 12.88 | 11.48% |
| 86 | 50 | |||||
| 69 | 64 | |||||
| 69 | 64 | |||||
| 12 | 5 | 79 | 64 | 19.23 | 18.22 | 5.25% |
| 79 | 50 | |||||
| 65 | 32 | |||||
| 73 | 40 | |||||
| 73 | 40 | |||||
| 13 | 5 | 73 | 64 | 27.41 | 26.29 | 4.09% |
| 90 | 64 | |||||
| 90 | 64 | |||||
| 72 | 80 | |||||
| 72 | 80 | |||||
| 14 | 1 | 64 | 32 | 2.55 | 2.71 | -6.27% |
| 15 | 2 | 54 | 25 | 4.50 | 4.65 | -3.33% |
| 59 | 32 | |||||
| 16 | 2 | 60 | 40 | 9.16 | 9.65 | -5.35% |
| 66 | 63 |
The entrance surface dose on the surface of Rando phantom, for single view images.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 1 | AP | 68 | 64 | 3.55 | 3.43 | 3.36 |
| 2 | AP | 72 | 64 | 3.84 | 3.74 | 3.76 |
| 3 | AP | 70 | 80 | 4.37 | 4.79 | 4.46 |
| 4 | Lateral | 80 | 80 | 6.63 | 5.96 | 6.34 |
| 5 | Lateral | 85 | 80 | 6.67 | 6.61 | 7.14 |
| 6 | Lateral | 80 | 80 | 7.24 | 7.38 | 8.02 |
The entrance surface dose on the surface of Rando phantom, for multiple view images.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1 | 5 | AP | 68 | 64 | ------ | ------ | 3.68 |
| Lateral | 80 | 80 | ------ | ------ | 6.76 | ||
| Lateral | 80 | 80 | ------ | ------ | 6.76 | ||
| Oblique | 75 | 80 | ------ | ------ | 5.68 | ||
| Oblique | 75 | 80 | ------ | ------ | 5.68 | ||
| Total Dose in 5 views | ---- | ---- | 30.73 | 29.02 | 28.56 | ||
| 2 | 4 | AP | 68 | 64 | ------ | ------ | 3.74 |
| Lateral | 80 | 80 | ------ | ------ | 6.82 | ||
| Oblique | 75 | 80 | ------ | ------ | 5.56 | ||
| Oblique | 75 | 80 | ------ | ------ | 5.56 | ||
| Total Dose in 4 views | ---- | ---- | 23.40 | 21.46 | 21.66 | ||
| 3 | 2 | AP | 68 | 64 | ------ | ------ | 3.70 |
| Lateral | 80 | 80 | ------ | ------ | 6.38 | ||
| Total Dose in 2 views | ---- | ---- | 9.87 | 10.46 | 10.08 |
Figure 1Percentage difference between the dose measured by TLD-100, GR-200, and SoliDose
The minimum, maximum, and average absorbed doses to each organ
|
|
|
|
| |
|---|---|---|---|---|
| 5 |
AP | Kidney | (0.48-4.86) | 2.3 |
| Uterus | (0.94-7.62) | 3.2 | ||
| Soft tissue around spine | (1.7-2.50) | 2 |
Uncertainty analysis of TLD-100 results.
|
|
|
|
|---|---|---|
| Repetitive TLD measurements | 5.0 | ___ |
| TLD dose calibration | ___ | 5.0 |
| Correction for energy dependence of TLD | ___ | 0 |
| TLD positioning | ___ | 1.0 |
| Quadrature combination | 5.0 | 5.1 |
| Total uncertainty | 7.14 | |
Uncertainty analysis of GR-200 results.
|
|
|
|
|---|---|---|
| Repetitive TLD measurements | 4.0 | ___ |
| TLD dose calibration | ___ | 5.0 |
| Correction for energy dependence of TLD | ___ | 0 |
| TLD positioning | ___ | 1.0 |
| Quadrature combination | 4.0 | 5.1 |
| Total uncertainty | 6.48 | |
Comparison of the results with other investigations.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
| 1 | TLD-100 | 5.64 | All projections | Lumbar spine | ------- | Iran | This work |
| GR-200 | 5.46 | ||||||
| Solidose 400 | 5.4 | ||||||
| 2 | TLD-100 | 3.92 | AP | Lumbar spine | ------- | Iran | This work |
| GR-200 | 3.98 | ||||||
| Solidose 400 | 3.86 | ||||||
| 3 | TLD-100 | 6.84 | Lateral | Lumbar spine | Iran | This work | |
| GR-200 | 6.64 | ||||||
| Solidose 400 | 7.16 | ||||||
| 4 | ------- | ------- | AP | Lumbar spine | 5 | UK |
[ |
| 5 | ------- | ------- | Lateral | Lumbar spine | 11 | UK |
[ |
| 5 | ------- | ------- | AP | Lumbar spine | 8 | Ireland |
[ |
| 6 | -------- | ------- | Lateral | Lumbar spine | 24 | Ireland |
[ |